back to all entries

Rhode Island Passes Groundbreaking Bill for Fibroid Care Access

September 14,2022

Rhode Island became the first state in the nation to pass a bill in June, 2022, that ensures coverage for all uterine fibroid treatment options, including uterine fibroid embolization (UFE).

The groundbreaking legislation, H 7561, takes effect on January 1, 2023. It includes insurance coverage in Rhode Island for fibroid treatment UFE, and other procedures including both open and laparoscopic hysterectomy, open and laparoscopic myomectomy. Bill supporters say this is an important step to improving access to care including minimally and non-invasive fibroid treatment options.

Fibroids are benign tumors that develop in or on the uterine wall. Symptoms can include: heavy or prolonged periods, lower back pain, bloated abdomen, and severe cramping. An estimated 26 million American women struggle with fibroids often-debilitating condition. In fact, 70-80 percent of women will develop fibroids before they reach 50.

While minimally invasive options exist to treat fibroids, hysterectomies remain the number one choice presented to women upon diagnosis. A 2017 poll by the Society of Interventional Radiology found that 44 percent of women that are diagnosed with fibroids are not aware of minimally to non-invasive treatments for uterine fibroids.1

This legislation will provide women in Rhode Island the opportunity to make informed decisions about their health and explore treatment options.

Under this bill the Rhode Island Department of Health and Human Services must:

  • research solutions for fibroid disease in conjunction with the National Institute of Health and other relevant agencies,
  • create a database of fibroid services for people who receive Medicaid or the Children’s Health Insurance Program (CHIP),
  • track and report the financial cost of these services,
  • provide healthcare providers and the public information about fibroids, including information about minority women being at higher risk.

“Fibroid Fighters supports Rhode Island House Bill 7561,” said Dr. Yan Katsnelson, Founder and CEO, Fibroid Fighters. “We hope this legislation will spark similar nationwide legislation. The conversation must continue.”

Learn more about Fibroid Fighters’ support of national legislation that improves fibroid education and promotes research.

Join the fight with us. We want to educate the public so fibroid research and less invasive treatment options become standard. If you suffer or have experienced fibroids, you can make a difference in your community by talking about your fibroid journey.

Tell your story.

1 Society of Interventional Radiology, “Women largely unaware of minimally invasive treatment for uterine fibroids. https://www.sirweb.org/media-and-pubs/media/news-release-archive/news-release-UFE-082917

Other Posts

Fibroid News Update
02/02/24

New Hope for Uterine Fibroid Treatment: Targeting Tumors Beyond Hormones

Uterine fibroids are a common and often painful condition affecting nearly eight in ten women at some point in their lives. While typically not life-threatening, these noncancerous tumors can cause

Drub Therapy
08/29/23

Clinical Trial Looks at Reducing Endometriosis and Uterine Fibroid Symptoms 

A clinical trial investigated reducing symptoms and severity of uterine fibroids and endometriosis using a combination of oral therapy was found to be promising. Fibroids and endometriosis are two common

Latest News Sept.
08/28/23

Study Compares Fibroid Treatments

In a recent study published in Medical Express, researchers compared the cost-effectiveness of surgical treatments for uterine fibroids.   Surgery is the most frequent treatment for uterine fibroids. However, procedures like